• Malcolm Bundey CEO Pact Group
    Malcolm Bundey CEO Pact Group
Close×

Pact Group's four acquisitions in the last year have helped it to a record profit of $85.1 million for the 2016 financial year.

The packaging company's profits were up 25.8 per cent from 2015, and revenue rose about 10 per cent to $1.39 billion.

Pact purchased Jalco for $80 million in September last year, and made three other acquisitions which contributed to its earnings.

Its Efficiency Program, announced in 2015, is now substantially complete, with $6.6 million in efficiency savings delivered during the year, slightly ahead of expectation.

Chief executive Malcolm Bundey told the Australian Financial Review there was still “a robust pipeline” of potential acquisitions for Pact both in Australia and in Asia and New Zealand, where it bought the Fruit Case company in July.

Revenue and earnings in Pact's Australian business, which is responsible for about 75 per cent of the group's result, grew strongly, but fell in Pact's international business.

Pact said the volume of its packaging manufacturing had been hit in the agricultural and dairy sectors due to weak global dairy markets and unfavourable weather as well as lower demand in the industrial sector that was influenced by weaker mining markets.

Demand across other sectors was also subdued.

Bundey said the company was well placed, though, in terms of spreading risk across the business, with no customer accounting for any more than 5-6 per cent of income.

Food & Drink Business

Pure Wine Co has been appointed as the exclusive national mainland distributor for Tasmanian winery, Pipers Brook Vineyard. Effective from 1 March, Pure Wine Co will manage national mainland distribution and trade sales for Pipers Brook and its Kreglinger Sparkling, Pipers Tasmania and Ninth Island labels.

The fourth round of the federal government’s Traceability Grants Program is now open for applications, with funding from $50,000 to $500,000 available for projects modernising and enhancing agricultural traceability systems.

The rapid rise of GLP-1 weight loss medications is driving profound changes in consumer behaviour overseas – and Australia’s retail sector should prepare now. New data from Circana shows GLP-1 uptake has already reached meaningful scale in Australia, with 12 per cent of households reporting at least one member using a GLP-1 medication, as of September 2025.